In breast cancer, Ras-induced CXCL10 overexpression contributes to the development of breast tumours (Parl et al., 1984), and overexpression of CXCR3 is associated with poorer overall survival (Bronger et al., 2017). This evidence concerns the gene CXCL10 and breast carcinoma.